Evidence-graded peptide profiles

The current heavyweight in obesity pharmacology. Bigger outcomes than semaglutide, bigger expectations, and zero room for sloppy titration. Not subtle. Very real.

The gut-healing peptide that actually has the receipts. Forty-plus studies, oral form that works, and a safety profile we can get behind. Our #1 recovery pick.

The GLP-1 that made peptide medicine mainstream. Real trial data, real weight loss, and very real GI tradeoffs. Legit, not effortless.

The systemic-feeling recovery peptide everyone pairs with BPC-157. Plausible mechanism, thinner evidence, and still not the same thing. Useful, not interchangeable.

The older-school GHRH peptide with real clinical history and much lower drama than the biohacker favorites. Sensible, milder, and not here to cosplay as HGH. Credible, not flashy.

The GHRH analog with real pathway signal and wildly inflated physique expectations. Better as a protocol tool than a personality trait. Legit, still not HGH.

The tidy GH secretagogue people reach for when older GHRPs feel too messy. Cleaner profile, moderate evidence, and still best used as part of a real protocol. Useful, not magical.

The copper peptide with a real wound-healing and skin-quality case, then a lot of extra marketing piled on top. Best when kept local and realistic.

The oral GH-axis compound people love because it skips injections. It also brings appetite, edema, and enough chaos to keep you honest. Convenient, not clean.

The calm-and-cognition peptide with enough signal to matter and enough uncertainty to keep the claims on a leash. Interesting, not automatic.

The longevity clinic darling with a real biological role and a much fuzzier intervention story. Interesting, expensive, and very easy to oversell. Hype still outpaces proof.

The longevity peptide that keeps showing up in telomere conversations for a reason, then gets sold far past that reason. Interesting, still unsettled.

The sleep peptide with a strong name and a much softer evidence base. Worth understanding, not worth pretending is proven. Curious, still thin.

The fat-loss peptide with a clean idea and a much less convincing scoreboard. Interesting design, weak payoff, and no reason to confuse it with real obesity medicine. More concept than category leader.